Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 12 October 2009, doi:10.1136/bmj.b4175
Cite this as: BMJ 2009;339:b4175
| The first 150 words of the full text of this article appear below. |
Guidelines on preventing venothromboembolism issued by the Department of Health in 2007 included documented mandatory risk assessment for every hospital patient. In our district general hospital all adult medical admissions have undergone such a process since April 2009. A risk assessment proforma is completed and the patient is then assigned a category—not at risk or requiring low molecular weight heparin or thromboembolus deterrent stockings, or both.
Recently the completion of this proforma has been audited locally. Favourable outcomes included full and early completion of the paperwork but the prescription of prophylaxis, or indeed its effective and timely administration, was not evaluated. Thus a patient could have a perfectly documented risk assessment but be receiving no clinical benefits. Does this equate to patient safety or good clinical practice?
Both risk management and audit are important but can compromise time spent with patients. If they result in improved clinical practice and patient
Belinda Sandler, SHO, cardiology1, John M Hounsell, registrar, cardiology1, Thomas Semple, house officer, cardiology1
1 Lister Hospital, Stevenage SG1 4AB
b.sandler@doctors.net.uk
Read all Rapid Responses